Key facts
- Active LCDs
- 113
- Contracts
- 13
- 05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202
- States and territories
- 48
- AK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS MT NC ND NE NH NJ NM NV OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY
- Contractor site
- med.wpsgha.com/
Jurisdictions
Contract numbers identify the jurisdiction on remittances and in the Medicare Coverage Database; A and B MAC contracts cover both institutional and professional claims, while DME and HHH contracts are national or regional specialty jurisdictions.
| Contract | Type | States |
|---|---|---|
| 05101 | MAC - Part A | IA |
| 05102 | MAC - Part B | IA |
| 05201 | MAC - Part A | KS |
| 05202 | MAC - Part B | KS |
| 05301 | MAC - Part A | MO |
| 05302 | MAC - Part B | MO |
| 05401 | MAC - Part A | NE |
| 05402 | MAC - Part B | NE |
| 05901 | MAC - Part A | AK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS MT NC ND NE NH NJ NM NV OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY |
| 08101 | MAC - Part A | IN |
| 08102 | MAC - Part B | IN |
| 08201 | MAC - Part A | MI |
| 08202 | MAC - Part B | MI |
Most recently effective LCDs
Revision effective dates signal where this contractor has tightened or loosened criteria; the ten newest are listed first, with the full list below.
| LCD | Title | Effective |
|---|---|---|
| L40300 | Peripheral Nerve Injections and Procedures for Chronic Pain | 2026-10-25 |
| L40274 | MolDX: Genetic Testing for Hereditary Thrombophilia | 2026-10-12 |
| L40278 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | 2026-10-12 |
| L40341 | Allergy Diagnostic Testing | 2026-09-27 |
| L38441 | MolDX: Blood Product Molecular Antigen Typing | 2026-09-24 |
| L40249 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | 2026-08-30 |
| L34614 | Colonoscopy and Sigmoidoscopy-Diagnostic | 2026-08-27 |
| L39051 | Cosmetic and Reconstructive Surgery | 2026-08-27 |
| L39907 | Micro-Invasive Glaucoma Surgery (MIGS) | 2026-08-27 |
| L39911 | Total Joint Arthroplasty | 2026-08-27 |
All active LCDs (113)
- L36408 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40341 Allergy Diagnostic Testing
- L36402 Allergy Testing
- L39477 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39624 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39913 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L35124 Autonomic Function Testing
- L37216 BDX-XL2
- L34648 Bisphosphonate Drug Therapy
- L34528 Blepharoplasty, Blepharoptosis and Brow Lift
- L39909 Botulinum Toxin Injections
- L39905 Cataract Surgery
- L35490 Category III Codes
- L39788 Cervical Fusion
- L37205 Chemotherapy Drugs and their Adjuncts
- L38837 Colon Capsule Endoscopy (CCE)
- L34614 Colonoscopy and Sigmoidoscopy-Diagnostic
- L38211 Corneal Hysteresis
- L35121 Coronary Computed Tomography Angiography (CCTA)
- L39051 Cosmetic and Reconstructive Surgery
- L34636 Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring)
- L34659 Endoscopic Treatment of GERD
- L39054 Epidural Steroid Injections for Pain Management
- L34633 Erythropoiesis Stimulating Agents (ESAs)
- L38841 Facet Joint Interventions for Pain Management
- L37537 Frequency of Hemodialysis
- L38528 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L34771 Immune Globulins
- L34596 Immunizations
- L38686 Implantable Continuous Glucose Monitors (I-CGM)
- L39529 Intraarticular Knee Injections of Hyaluronan
- L34623 Intraoperative Neurophysiological Testing
- L36805 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L37772 MDS FISH
- L39907 Micro-Invasive Glaucoma Surgery (MIGS)
- L35494 Mohs Micrographic Surgery
- L40272 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L36523 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L38441 MolDX: Blood Product Molecular Antigen Typing
- L36811 MolDX: Breast Cancer Assay: Prosigna®
- L37913 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37210 MolDX: Decision Dx-UM (Uveal Melanoma)
- L37663 MolDX: EndoPredict® Breast Cancer Gene Expression Test
- L37919 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L39709 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L40274 MolDX: Genetic Testing for Hereditary Thrombophilia
- L39989 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L36400 MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L37003 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L37921 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L39040 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L37001 MolDX: MGMT Promoter Methylation Analysis
- L38018 MolDX: Melanoma Risk Stratification Molecular Testing
- L38835 MolDX: Minimal Residual Disease Testing for Cancer
- L39479 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39614 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39481 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39711 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39042 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L36807 MolDX: Molecular Diagnostic Tests (MDT)
- L39044 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39356 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39987 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39720 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L40249 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L36797 MolDX: NRAS Genetic Testing
- L38176 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38158 MolDX: Next-Generation Sequencing for Solid Tumors
- L40278 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40022 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L37199 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L38435 MolDX: Pharmacogenomics Testing
- L38678 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38178 MolDX: Pigmented Lesion Assay
- L38168 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38443 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38684 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L37539 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L38433 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38429 MolDX: Repeat Germline Testing
- L35222 Nerve Blocks for Peripheral Neuropathy
- L34594 Nerve Conduction Studies and Electromyography
- L35998 Non-Coronary Vascular Stents
- L35755 Non-Invasive Abdominal / Visceral Vascular Studies
- L35753 Non-Invasive Cerebrovascular Studies
- L38839 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L35761 Non-Invasive Peripheral Arterial Vascular Studies
- L35751 Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
- L35486 Pelvic Floor Dysfunction: Anorectal Manometry and EMG
- L34761 Percutaneous Coronary Interventions
- L38213 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L36000 Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain
- L40300 Peripheral Nerve Injections and Procedures for Chronic Pain
- L36839 Polysomnography and Other Sleep Studies
- L37011 ProMark® Risk Score
- L34616 Psychiatry and Psychology Services
- L34646 Psychological and Neuropsychological Testing
- L35498 Removal of Benign Skin Lesions
- L39475 Sacroiliac Joint Injections and Procedures
- L34760 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34624 Somatosensory Testing
- L40193 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L34526 Surgical Treatment of Obstructive Sleep Apnea (OSA)
- L39911 Total Joint Arthroplasty
- L34641 Transcranial Magnetic Stimulation (TMS)
- L38682 Transurethral Waterjet Ablation of the Prostate
- L34536 Treatment of Varicose Veins of the Lower Extremities
- L39713 Trigger Point Injections
- L34645 Urine Drug Testing
- L37015 Visual Electrophysiology Testing
- L34615 Visual Fields
- L34658 Vitamin D Assay Testing
- L37228 Wound Care
How to use this contractor's policies
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so the first question is which jurisdiction the rendering location falls in; the contracts table above answers that for institutional and professional claims, and durable medical equipment follows the DME MAC region instead. Each LCD states the covered indications, the documentation the record must contain and, through its companion Billing and Coding Article, the ICD-10 codes that support medical necessity and the HCPCS codes the policy edits. When a claim denies with CARC 50 and remark N115, the remark names the LCD; open it from the list above, compare the diagnosis on the claim with the article's covered list, and build the appeal on the documentation requirements rather than on the policy itself. Where this contractor has no LCD for a service and no National Coverage Determination exists, coverage is decided claim by claim under the reasonable-and-necessary standard, which is where prior authorization and pre-service review earn their keep.
Frequently asked questions
Which states does Wisconsin Physicians Service Insurance Corporation cover?
Wisconsin Physicians Service Insurance Corporation holds 13 Medicare contracts (05101 MAC - Part A; 05102 MAC - Part B; 05201 MAC - Part A; 05202 MAC - Part B; 05301 MAC - Part A; 05302 MAC - Part B; 05401 MAC - Part A; 05402 MAC - Part B; 05901 MAC - Part A; 08101 MAC - Part A; 08102 MAC - Part B; 08201 MAC - Part A; 08202 MAC - Part B) covering AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.
How many LCDs does Wisconsin Physicians Service Insurance Corporation have?
113 Local Coverage Determinations are active in the current Medicare Coverage Database export for Wisconsin Physicians Service Insurance Corporation. Each LCD applies only in that contractor's jurisdiction, so the same service can be covered differently in a neighbouring state.
What is the difference between an LCD and an NCD?
A National Coverage Determination is set by CMS and binds every contractor. A Local Coverage Determination is written by one Medicare Administrative Contractor for its jurisdiction and cannot conflict with an NCD; where no NCD exists, the LCD is the controlling policy.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file lcd.csvSHA-256 2fcc4251b6ddd1eb…
Disclaimer
Contractor jurisdictions and LCD lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify coverage against the current LCD text on cms.gov or the contractor site before billing. Not legal, clinical or billing advice.